Showing 1 to 1 of 1 results
forbes.com
🌐 85% Global Worthiness


FDA Clears Lumipulse Blood Test for Early Alzheimer's Detection
The FDA cleared Lumipulse, a blood test detecting Alzheimer's amyloid plaques in symptomatic adults over 55, improving early diagnosis and access to new treatments, potentially reducing reliance on expensive and invasive procedures.
FDA Clears Lumipulse Blood Test for Early Alzheimer's Detection
The FDA cleared Lumipulse, a blood test detecting Alzheimer's amyloid plaques in symptomatic adults over 55, improving early diagnosis and access to new treatments, potentially reducing reliance on expensive and invasive procedures.
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results